This program is not sponsored or programmed by the AAAAI.
Sunday, February 27, 2022
6:00 AM – 6:15 AM Local Time: Registration & Breakfast
6:15 AM – 7:30 AM Local Time: Symposium
Sheraton Phoenix Downtown
340 North Third Street
Phoenix, AZ 85004
Meeting room: Phoenix Ballroom DE, Third Level
Program Features
- Online personalized quality-improvement poster-generation portal
- Downloadable whiteboard animations
Faculty
Cecelia Damask, DO
Medical Director
Lake Mary ENT and Allergy
Lake Mary, FL
Stella E. Lee, MD
Section Chief, Rhinology
Division of Otolaryngology—Head and Neck Surgery
Department of Surgery
Brigham and Women’s Hospital
Harvard Medical School
Boston, MA
Learning Objectives
After completing the CME activity, learners should be better able to:
- Define the burden and pathophysiology of chronic rhinosinusitis with nasal polyps (CRSwNP)
- Evaluate clinical data and biomarkers concerning the use of novel anti-inflammatory biologics for the management of CRSwNP
- Apply best practices for the interdisciplinary development of individualized treatment plans for patients with CRSwNP
Target Audience
This activity is designed to meet the educational needs of allergists, otolaryngologists, primary care physicians, nurses, nurse practitioners, pharmacists, and other members of the multidisciplinary team to ensure an up-to-date understanding of the latest data in management of chronic rhinosinusitis with nasal polyps.
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com
